Dr. Singh shares if hormonal or anti-hormonal therapies can be used to treat ovarian cancer.
We’re sort of figuring out more and more that, ovarian cancer probably is a hormonally responsive disease, and so we’re learning over time that we can see some responses using therapies like Tamoxifen which is an anti-estrogen, aromatase inhibitors, progesterones, that there is interplay, and so there are people in whom there is a role for hormonal or anti-hormonal therapy. Those are less proven and sort of less by the book as surgery, chemo is.
About Dr. Diljeet K. Singh, M.D., Dr.P.H.:
Dr. Diljeet K. Singh, M.D., Dr.P.H., is a gynecologic oncologist and is Co-Director of the Northwestern Ovarian Cancer Early Detection and Prevention Program. She is part of the Division of Gynecologic Oncology at the Robert H. Lurie Comprehensive Cancer Center of the Feinberg School of Medicine at Northwestern University in Chicago, Illinois.
Dr. Singh attended medical school at the Feinberg School of Medicine at Northwestern University. She completed her residency at Johns Hopkins Hospital in Baltimore, Maryland, and her fellowship at the University of Texas MD Anderson Cancer Center in Houston, Texas.
Dr. Singh specializes in gynecologic, cervical, ovarian, uterine, vaginal, and vulvar cancers.